MY197301A - Novel peptides and combination of peptides for use in immunotherapy against lung cancer, including nsclc and other cancers - Google Patents
Novel peptides and combination of peptides for use in immunotherapy against lung cancer, including nsclc and other cancersInfo
- Publication number
- MY197301A MY197301A MYPI2019005993A MYPI2019005993A MY197301A MY 197301 A MY197301 A MY 197301A MY PI2019005993 A MYPI2019005993 A MY PI2019005993A MY PI2019005993 A MYPI2019005993 A MY PI2019005993A MY 197301 A MY197301 A MY 197301A
- Authority
- MY
- Malaysia
- Prior art keywords
- peptides
- combination
- present
- cancers
- tumor
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 7
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 6
- 206010028980 Neoplasm Diseases 0.000 title abstract 4
- 238000009169 immunotherapy Methods 0.000 title abstract 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 title 1
- 201000005202 lung cancer Diseases 0.000 title 1
- 208000020816 lung neoplasm Diseases 0.000 title 1
- 108700018351 Major Histocompatibility Complex Proteins 0.000 abstract 2
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 2
- 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 abstract 2
- 108091008874 T cell receptors Proteins 0.000 abstract 1
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 abstract 1
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 1
- 230000005975 antitumor immune response Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 230000001024 immunotherapeutic effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor- associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MYPI2019005993A MY197301A (en) | 2017-07-17 | 2017-07-17 | Novel peptides and combination of peptides for use in immunotherapy against lung cancer, including nsclc and other cancers |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MYPI2019005993A MY197301A (en) | 2017-07-17 | 2017-07-17 | Novel peptides and combination of peptides for use in immunotherapy against lung cancer, including nsclc and other cancers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY197301A true MY197301A (en) | 2023-06-12 |
Family
ID=87761105
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2019005993A MY197301A (en) | 2017-07-17 | 2017-07-17 | Novel peptides and combination of peptides for use in immunotherapy against lung cancer, including nsclc and other cancers |
Country Status (1)
| Country | Link |
|---|---|
| MY (1) | MY197301A (en) |
-
2017
- 2017-07-17 MY MYPI2019005993A patent/MY197301A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12017501275A1 (en) | Novel peptides and combination of peptides for use in immunotherapy against lung cancer, including nsclc and other cancers | |
| PH12018500551A1 (en) | Novel peptides and combination of peptides for use in immunotherapy against various cancers | |
| PH12018500848A1 (en) | Novel peptides and combination of peptides for use in immunotherapy against cll and other cancers | |
| PH12018500864A1 (en) | Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers | |
| PH12018501865B1 (en) | Peptides and combination of peptides for use in immunotherapy against non-small cell lung cancer and other cancers | |
| EP3875467A3 (en) | Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers | |
| PH12019501377A1 (en) | Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers | |
| WO2018189152A3 (en) | Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers | |
| SG10201806839PA (en) | Novel peptides and combination of peptides for use in immunotherapy against various tumors | |
| MY203318A (en) | Novel peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers | |
| PH12019502308A1 (en) | Peptides and combination thereof for use in the immunotherapy against cancers | |
| PH12018500004A1 (en) | Novel peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers | |
| PH12020500051A1 (en) | Novel peptides and combination of peptides for use in immunotherapy against lung cancer, including nsclc, sclc and other cancers | |
| MX2018010875A (en) | Novel peptides and combination of peptides for use in immunotherapy against various tumors. | |
| PH12018502159A1 (en) | Immunotheraphy against melanoma and other cancers | |
| PH12019502300A1 (en) | Peptides and combination of peptides for use in immunotheraphy against leukemias and other cancers | |
| PH12020551958A1 (en) | Peptides for use in immunotherapy against cancers | |
| MY196837A (en) | Novel peptides and combination of peptides for use in immunotherapy against various cancers | |
| PH12017501467A1 (en) | Novel peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers | |
| PH12018502108A1 (en) | Novel peptides and combination of peptides for use in immunotherapy against aml and other cancers | |
| PH12018500665A1 (en) | Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers | |
| PH12018501639A1 (en) | Novel peptides and combination of peptides for use in immunotherapy against nhl and other cancers | |
| MY197301A (en) | Novel peptides and combination of peptides for use in immunotherapy against lung cancer, including nsclc and other cancers | |
| MY197794A (en) | Novel peptides and combination of peptides for use in immunotherapy against lung cancer, including nsclc and other cancers | |
| MY197679A (en) | Novel peptides and combination of peptides for use in immunotherapy against lung cancer, including nsclc and other cancers |